Skip to main content
Premium Trial:

Request an Annual Quote

Genome Canada Awards $9.24M for Genomics, Proteomics Research

NEW YORK (GenomeWeb News) – Non-profit group Genome Canada announced today that it will provide CDN$9.37 million (US$9.24 million) to 13 winning projects in the Genome Canada Technology Development Competition.
 
The competition received 51 proposals for genomics and proteomics projects from across Canada. Genome Canada, which receives funding from the Candian government and international partners, said the winners received an additional CDN$9.63 million in co-funding from Canadian and international partners.
 
Among the winners are a study of mass spectrometry-based proteomics for drug development and design being conducted by Christoph Borchers at the University of Victoria in British Columbia; a study of single cell genomics led by Carl Hansen and Marco Marra at the University of British Columbia; and a study of environmental barcoding using massively parallel sequencing led by Paul Hebert at the Biodiversity Institute of Ontario. A full list of the grant winners can be found here.
 
The projects will begin this spring and run for two years, Genome Canada said.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.